Corcept Therapeutics Inc
NASDAQ:CORT
| Market Cap (Intraday) | 2.19B |
| Current PE | 22.48 |
| Forward PE | 22.82 |
| 2yr Forward PE | 19.12 |
| 10-Day MA | $20.51 |
| 50-Day MA | $20.70 |
| 200-Day MA | $23.10 |
Corcept Therapeutics Inc Stock, NASDAQ:CORT
149 Commonwealth Drive, Menlo Park, California 94025
United States of America
Phone: +1.650.327.3270
Number of Employees: 236
Description
Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development and commercialization of medications to treat severe metabolic, oncologic and psychiatric disorders. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol. Its products include korlym and korlym support. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA.